Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

  1. Pérez de Ciriza, C.
  2. Moreno, M.
  3. Restituto, P.
  4. Bastarrika, G.
  5. Simón, I.
  6. Colina, I.
  7. Varo, N.
Revue:
Clinical Biochemistry

ISSN: 1873-2933 0009-9120

Année de publication: 2014

Volumen: 47

Número: 18

Pages: 272-278

Type: Article

DOI: 10.1016/J.CLINBIOCHEM.2014.09.004 GOOGLE SCHOLAR

Objectifs de Développement Durable